Sandoz To Pay $265M To Resolve Claims In Price-Fixing MDL
By Dan McKay · February 29, 2024, 6:09 PM EST
Swiss generic drug and biosimilar manufacturer Sandoz announced Thursday that two of its subsidiaries have reached a $265 million settlement with the direct purchasers of generic medications to resolve allegations of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login